diabetestalk.net

Fitbit Ionic Glucose Monitoring

  1. Blood Sugar
  2. Fitbit Ionic Glucose Monitoring
A Future Fitbit Could Track Your Glucose, Company's Latest Investment Hints

A Future Fitbit Could Track Your Glucose, Company's Latest Investment Hints

A future Fitbit could track your glucose, company's latest investment hints Fitbit invests $6 million in coin-size glucose tracker patch The health-based arms race between Apple and Fitbit is heating up. Everyone knows Apple is working toward a device that could track glucose, even if it's years away. Fitbit is looking to catch up, as its latest investment proves. CNBC reports that Fitbit has invested $6 million into a company called Sano, which makes a coin-size patch that can track glucose and help diabetics manage their condition. It's Fitbit's first investment in a company, and CEO James Park tells CNBC Sano fits into Fitbit's larger strategy of complete health solutions. Read this: How wearable tech is helping diabetics "I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment," he said. It's not difficult to see what that means. Fitbit wants to be able to deliver some tight Sano integration, so that you wear the patch and get the information beamed directly to your Fitbit. The company already has a partnership with Dexcom , but Dexcom also has a similar partnership with Apple. Sano would give Fitbit something a little more unique and a little more convenient, since it is just a coin-sized patch. However, the one downside to Sano is that it's invasive. The patch has tiny little needles on it, though Sano CEO Ashwin Pushpala said it's both less painful and cheaper than other invasive glucose-tracking options. So when will you get your hands on one of these patches? Well, you'll have to wait just over a year. They're intended for people with either Type 1 or 2 diabetes, however people who don't have diabetes and just want to monitor their Continue reading >>

Fitbit Has Invested $6 Million In Glucose-monitoring Startup Sano

Fitbit Has Invested $6 Million In Glucose-monitoring Startup Sano

Fitbit has invested $6 million in glucose-monitoring startup Sano Fitbit has invested $6 million in a glucose-monitoring startup called Sano, in what appears to be part of Fitbits larger plans to make its fitness devices more valuable for overall health. The investment was first reported by CNBC earlier today ; The Verge independently confirmed the investment. Sano , founded in 2011, is a San Francisco-based company that has been working on what it describes as a minimally invasive, continuous glucose monitor that youd wear on your skin like a patch. The product doesnt appear to have shipped yet, and its unclear whether this would be sold directly to consumers, or whether it will require FDA approval. That depends on what kind of claims the company is making about the technology. Minimally invasive glucose monitoring which means not drawing blood or monitoring the interstitial fluid just below the skin is a trend among some of the worlds biggest tech companies. Alphabet company Verily says its working on a miniaturized continuous glucose monitor . Apple is said to be working on some type of needle-less blood sugar tracker though as The Verges Rachel Becker has reported, its incredibly difficult to accurately test blood sugar without breaking the skin . In September of last year, Fitbit said that it was partnering with Dexcom, Inc. to bring a continuous glucose-monitoring display to the Fitbit Ionic smartwatch. Fitbit has also said its working on a solution for tracking sleep apnea, though again, that may require more advanced technology than Fitbits current slate of products offers . Continue reading >>

Fitbit Invests In Diabetes Data And Medtech

Fitbit Invests In Diabetes Data And Medtech

We're sorry, an error occurred. We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later. If you didn't believe before that the wearable activity tracker company Fitbit was really invested in diabetes, believe it now. Recent headlines indicate that the San Francisco company is going all in for diabetes: collaborating with Dexcom to soon offer a new Fitbit Ionic smartwatch that will specifically display diabetes CGM data; giving One Drop users access to Fitbit data and working with them on a custom diabetes mobile app; partnering with Medtronic in late 2016 on the professional CGM front for T2s; most recently, working with major insurance provider UnitedHealthcare on a pair of fitness and glucose monitoring programs This is exciting because Fitbit is forging a path to give health insurers strong incentives to provide patients with the latest technology and tie their success with those tools to cost savings. Most of their current efforts are aimed at type 2 diabetes -- clearly the bigger market -- but the reason this is exciting for all PWDs is that Fitbit is forging a path for health insurance providers to have strong incentives to provide patients with the latest technology (CGM and data sharing) and tie success with those tools to cost savings. Thumbs up! "Fitbit(also) sees potential in other chronic disease categories that include: heart health,sleep disorders and mental health," a spokeswoman told us. This dovetails with what the Fitbit CEO said during the recent JP Morgan Healthcare conference, about moving from tracking steps to helping people live healthier . Here's a closer look at what Fitbit has on tap in the diabetes arena, and how they're tying in payer incentives to promote overall health: UHC ha Continue reading >>

The Fitbit Ionic Glucose Monitoring Smartwatch | Ireviews

The Fitbit Ionic Glucose Monitoring Smartwatch | Ireviews

By Michael J. Marquis , @MarquisInteract | September 13, 2017 in Smart Watch Were just one month away from Fitbits scheduled ship date of its Ionic smartwatch. Fitbits newest wearable device comes equipped with state-of-the-art GPS tracking, on-device dynamic workout programs, an intuitive heart rate tracking feature, and is water resistant up to 50 meters. Poised to compete with some of the biggest names in smart watches ( Samsung , Garmin , Tag Heuer , LG , and Apple ), Fitbit has added an impressive technology feature that none of the industry elites have (as of today): Glucose monitoring courtesy of DexCom, Inc. With more than 400 million people around the world living with diabetes, according to The World Health Organization, its time that a leading global wearables brand incorporates glucose monitoring into their smartwatch technology. Fitbit found the perfect partner in crime to make this all happen. Dexcoms CGM (continuous glucose monitoring system) is a revolutionary sensor that measures glucose levels subcutaneously (just beneath the skin) and wirelessly transmits data to Fitbits iOS/Android compatible smart app. It then sends the levels, in real-time, to the wearers wrist giving those with diabetes instant readings on their glucose levels at all times. The strength of our brand and our ability to track critical health metrics continuously for up to 4-plus days, coupled with Dexcoms market leadership in CGM, present a powerful combination that we hope will help millions of people better manage their diabetes, says James Park, CEO of Fitbit in a recent press release. With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users. Beginn Continue reading >>

Dexcom, Unitedhealth Team Up For Wearable Glucose Management Pilot Program

Dexcom, Unitedhealth Team Up For Wearable Glucose Management Pilot Program

Dexcom, UnitedHealth team up for wearable glucose management pilot program Updated Jan. 17 to include confirmation of Fitbits participation. UnitedHealth (NYSE: UNH ) and Dexcom (NSDQ: DXCM ) are joining forces to launch an individualized glucose management pilot program to help people with Type II diabetes manage their condition in real-time using wearable tech. People using UnitedHealths Medicare Advantage plan are eligible touse Dexcoms mobile continuous glucose monitoring system to track their blood sugar levels. Participating in the program also gives people access to personalized diabetes coaching and an activity tracker, the companies reported this week. With more than 27 million people nationwide living with Type II diabetesthere is urgent need to address this epidemic in new ways, Brian Thompson, CEO of UnitedHealthcare Medicare & Retirement, said in prepared remarks. Continuous glucose monitoring can be a game changer for people enrolled in our Medicare Advantage plans, as the data can be translated into personalized information that can be acted upon in real time. Dexcom is thrilled to work with UnitedHealthcare to bring this program to people living with diabetes, Steve Pacelli, Dexcoms EVP of strategy and corporate development, added. The insights that CGM and this program provide can drive significant value to both patients and care providers in helping to better manage diabetes. The pilot was showcased this week at the International Consumer Electronics Show in Las Vegas. Reporting from the conference, The Verges senior technology editor Lauren Goode wrote on Twitter that Dexcom and UnitedHealth are working with Fitbit (NYSE: FIT ) as part of the program. A spokesperson for Fitbit confirmed the companys involvement in the pilot program, writing in an ema Continue reading >>

Dexcom Continuous Glucose Monitor

Dexcom Continuous Glucose Monitor

Auto-suggest helps you quickly narrow down your search results by suggesting possible matches as you type. when will the Dexcom g5 system be able to communicate directly with the Fitbit ionic. is there a date or an expected time. I have found multiple articles saying that this is going to happen but no dates. Fitbit Community Council members are a select group of volunteers who share support knowledge on the forums and advocate for the betterment of Fitbit products and services. Learn more No dates that I am aware of. It is still just wait unfortunately. Be sure to visit Fitbit help if more assistance is needed. Ill be buying an Ionic as soon as the Dexcom app is released. Looking forward to it! Will it ever be able to synch with FreeStyle Libre system as well. Hello, I just talked to someone from Fitbit today and was told there is no for sure answer yet as to whether fitbit will have an update available that would make current watches dexcom compatible or whether it would need to be a whole new watch. I am hoping to hear something more solid pretty soon as I am sure many of you are as well! I am have without a fitbit for a while now hoping to hold off for a dexcom compatible watch. I'm so friggin tired of lack of transparency to dexcom/fitbit claims. There were numerous articles back in 3QTR 2017, and now we've been in the DARK for months. I bought a FITBIT Ionic for xmas expecting the compatibility with dexcom, and im ready to bail. The watch sucks overall compared to other smartwatches with GPS. Come out and indicate what is going on, please! I'm in the same boat. I bought the Ionic, thinking the integration would soon be implemented. I just talked to someone at Fitbit customer support who said they have no timeline, that Dexcom is developing the app, so he put it o Continue reading >>

Fitbit And Dexcom To Develop Continuous Glucose Monitoring (cgm) Experience For People Living With Diabetes

Fitbit And Dexcom To Develop Continuous Glucose Monitoring (cgm) Experience For People Living With Diabetes

Fitbit and Dexcom to Develop Continuous Glucose Monitoring (CGM) Experience for People Living with Diabetes Home / Why Choose Dexcom for Patient Care / Industry News / Fitbit and Dexcom to Develop Continuous Glucose Monitoring (CGM) Experience for People Living with Diabetes Dexcom CGM users will be able to see CGM data on Fitbit Ionic providing a convenient and discreet way to track glucose levels on wrist for users of both Android and iOS devices SAN FRANCISCO AND SAN DIEGO, CA September 7, 2017 Fitbit (NYSE: FIT), the leading global wearables brand, and DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, today announced a collaboration to develop and market products to help people better manage their diabetes and get a more complete picture of their overall health with easy-to-use mobile tools. The first planned initiative is to bring Dexcom CGM data to Fitbits new smartwatch, Fitbit Ionic. Through this experience, Dexcom CGM users on either Android or iOS devices would be able to see both activity and glucose levels, right on their wrist. The strength of our brand and our ability to track critical health metrics continuously for up to 4+ days1, coupled with Dexcoms market leadership in CGM, present a powerful combination that we hope will help millions of people better manage their diabetes, said James Park, CEO of Fitbit. With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users. Dexcom CGM Display on Fitbit Ionic will provide data for those living with diabetes The World Health Organization estimates2 that more than 400 million people around the world are living with diabetes. For t Continue reading >>

Fitbit Announces Deal To Bring Glucose Monitoring Data To Its Ionic Smartwatch

Fitbit Announces Deal To Bring Glucose Monitoring Data To Its Ionic Smartwatch

Fitbit Announces Deal to Bring Glucose Monitoring Data to its Ionic Smartwatch Friday September 8, 2017 3:48 AM PDT by Tim Hardwick Fitbit has announced a new partnership with glucose monitoring device company Dexcom that is set to bring diabetes monitoring capabilities to the fitness tracker company's new Ionic smartwatch. The deal initially means Ionic users will be able to connect a Dexcom device to the Fitbit app and seamlessly transfer up-to-date glucose level data to the smartwatch, making the information more easily accessible on their wrist. "The collaboration between Dexcom and Fitbit is an important step in providing useful information to people with diabetes that is both convenient and discreet," said Kevin Sayer, President and CEO, Dexcom. "We believe that providing Dexcom CGM data on Fitbit Ionic, and making that experience available to users of both Android and iOS devices, will have a positive impact on the way people manage their diabetes." There's nothing in the partnership to suggest the Ionic smartwatch will be able to give continuous glucose monitoring readouts on its own when it's released next month current continuous glucose monitoring systems require a small sensor that's worn under the skin to monitor glucose levels but Fitbit shares jumped 13 percent on the news, a high for the company since January, when it laid off some of its employees and announced its smartwatch plans. Dexcom also has a deal with Apple to bring its features to the Apple Watch this year, while owners of Dexcom monitors can already view their glucose data on an Apple Watch advanced devices by Dexcom include a transmitter, which can display glucose information directly to an iPhone app. Apple is thought to be working on a non-invasive real-time glucose monitor for a future v Continue reading >>

Unitedhealthcare, Dexcom Launch Wearable Glucose Management Pilot

Unitedhealthcare, Dexcom Launch Wearable Glucose Management Pilot

UnitedHealthcare, Dexcom Launch Wearable Glucose Management Pilot I read this article and found it very interesting, thought it might be something for you. The article is called UnitedHealthcare, Dexcom Launch Wearable Glucose Management Pilot and is located at UnitedHealthcare and DexCom, Inc. , has announced a glucose management pilot program driven by wearable technology to help people with Type 2 diabetes in real-time.Eligible UnitedHealthcare Medicare Advantage plan participants can use the Dexcom Mobile Continuous Glucose Monitoring (CGM) System to track their blood glucose levels 24/7, enabling them to understand how their behaviors affect their glucose so they can take appropriate actions. The pilot program is part of UnitedHealthcares focus on integrating human support with data from real-time sources, such as digital health technology, and historical sources, like claims data, to help improve and personalize how people navigate the health care system.Participants will receive personalized diabetes coaching and Fitbit devices wearable devices Fitbit Ionic or Fitbit Charge 2 to help them understand and act upon the data gathered by the CGM device. Together, these tools empower people with Type 2 diabetes to manage glucose levels and can result in increased glucose control, reductions in medications and improved confidence in managing their diabetes. RELATED: RCM: Getting the Most from Your States All-Payer Claims Database Dexcoms technology consists of a sensor usually worn on the abdomen that reads glucose levels just beneath the skin. A transmitter sends the data to a smartphone, which processes and displays updated data every five minutes, and can reveal relationships between eating, exercise and blood sugar that are difficult to observe with only test strip Continue reading >>

Fitbit Ionic Smartwatch To Display Dexcom Cgm Data In 2018

Fitbit Ionic Smartwatch To Display Dexcom Cgm Data In 2018

Fitbit Ionic Smartwatch to Display Dexcom CGM Data in 2018 New Dexcom and Fitbit collaboration to put CGM data on the wrist, a convenience win and the third smartwatch platform for Fitbit. What else might they develop? Dexcom and Fitbit recently announced an exciting diabetes collaboration, starting with a new device integration: Dexcom CGM data will be viewable on Fitbits new Ionic smartwatch as soon as possible in 2018. The news brings Dexcom CGM data to the third major smartwatch platform, expanding beyond the currently-available Apple Watch and Android Wear applications. Initially, Fitbit Ionic will likely display data relayed from the Dexcom G5 phone app, just as Apple Watch and Android Wear currently do (secondary display). Over time, its possible that direct CGM-to-watch communication might be added this would allow CGM data to be sent to the watch without the phone being present (primary display). Dexcom is already working on this direct communication with the Apple Watch, though there is no timeline on when it might be available. We see big convenience potential in such an update and hope it comes to Fitbit too. The collaboration between Fitbit and Dexcom will make it easier to see health and activity data alongside glucose data, which both companies hope will be an effective tool for users managing their diabetes. In addition, Dexcom CGM users will be able to connect with millions of people through Fitbits in-app Community, where they can ask questions, seek support, and share successes. Fitbit Ionic, like other Fitbit devices, provides users with real-time and long-term insights about their health, including activity, sleep patterns, resting heart rate, and cardio fitness level. In a big improvement over other smartwatches, Ionic includes a 4+ day battery li Continue reading >>

Dexcom And Fitbit Team Up To Tackle Diabetes Management

Dexcom And Fitbit Team Up To Tackle Diabetes Management

Dexcom and Fitbit team up to tackle diabetes management Will develop a wearable blood glucose tracking product Continuous glucose monitoring (CGM) specialists DexCom and wearable brand company Fitbit will team up to develop a new blood glucose tracking product for people with diabetes. The initiative will bring together Dexcoms CGM data and Fitbits new Ionic smart watch - which is compatible with both iOS and Android devices - to monitor activity and glucose levels from the users wrist. James Park, chief executive officer, Fitbit, said: Our ability to track critical health metrics coupled with Dexcoms market leadership in CGM present a powerful combination that we hope will help millions of people better manager their diabetes. According to the World Health Organization, more than 400 million people across the globe are estimated to be living with diabetes . Park added: With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users. The deal isnt Fitbits first life sciences partnership, and the Dexcom deal follows last years tie-up with medical device group Medtronic to integrate its CGM mobile app with the companys wearable . The future Fitbit-Dexcom device will come armed with a sensor to track a users heart rate and detect blood oxygen levels. Along with the Fitbits original capabilities, the Ionic will also feature GPS-tracking and on-device workouts, as well as smart features such as contactless payment, music, and notifications. Kevin Sayer, president and chief executive officer, Dexcom, said: The collaboration between Dexcom and Fitbit is an important step in providing useful information to people with diabetes that is both convenient and Continue reading >>

Fitbit Invests $6m In Glucose Monitoring Startup Sano

Fitbit Invests $6m In Glucose Monitoring Startup Sano

Fitbit invests $6M in glucose monitoring startup Sano Fitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed. "This fits into our strategy of looking beyond the device and thinking more about (health) solutions, Fitbit CEO James Park told CNBC . "I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment. Sano has developed a biometric sensor that is contained in a small patch. Though minimally invasive, the company claims the sensor is a completely painless way to continuously monitor the users glucose levels. The product also aims to help users understand the impact of their dietary decisions on their metabolism and gives users food suggestions, as well as exercise suggestions. The product has not yet hit the market but the companys webpage claims the product is totally affordable. Sanos webpage does not specifically mention diabetes, and in the past it has marketed itself as a tool for gathering metabolic insight for people who do not have diabeteswhich would let it skirt more stringent FDA clearance requirements. However, this could be a strategic investment for Fitbit that might help it jump into the diabetes management market. Sano launched in 2011 as part of an early Rock Healths accelerator program. Currently it has a total of $20.65 million in funding, according to Crunchbase ,including a $10 million round in June 2015. Interestingly,The company's team includes alums from Apple, Google, Samsung, and Fitbit. This isnt the first time Fitbit has dabbled with CGM products. In Se Continue reading >>

Fitbit's Ionic To Offer Glucose Monitoring For Diabetics

Fitbit's Ionic To Offer Glucose Monitoring For Diabetics

5 pictures Launched late last month, Fitbit's Ionic is the company's attempt at claiming some territory from smartwatch heavyweights like Apple and Garmin. Now the feature-packed wearable is set to gain a handy new piece of functionality, with the ability to display glucose levels on the user's wrist. Glucose monitoring has long shaped as a high-potential application for wearable devices. These could one day come in the form of contact lenses that change color as glucose levels hit dangerous levels, or small biosensors that monitor bodily fluids and send alerts via a smartphone app instead. The less time you spend thinking about your cargo, the more time you can spend running your busin... Dexcom, developer of glucose monitoring products, has taken the latter approach, and that seems to gel well with Fitbit's vision for wearable computing. Dexcom's CGM (continuous glucose monitoring system) consists of a small sensor that measures levels just beneath the skin and transmits data wirelessly to a smartphone app. But Dexcom and Fitbit have now joined forces to bring this data to the Ionic smartwatch. That means users of both Android and iOS devices will be able to have Dexcom's glucose data displayed on their wrist, beginning sometime in 2018. "The strength of our brand and our ability to track critical health metrics continuously for up to 4-plus days, coupled with Dexcom's market leadership in CGM, present a powerful combination that we hope will help millions of people better manage their diabetes," says James Park, CEO of Fitbit. "With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users." The Fitbit Ionic can be preordered for US$300, with Continue reading >>

Fitbit’s Ionic Smartwatch Will Help Diabetics Track Glucose Levels

Fitbit’s Ionic Smartwatch Will Help Diabetics Track Glucose Levels

Fitbit is pairing up with Dexcom, a company that creates continuous glucose monitoring (CGM) devices for people with diabetes. In an announcement today, the companies say that their first initiative is to bring Dexcom's monitoring device data to Fitbit's new Ionic smartwatch. For those unfamiliar, Dexcom's CGM devices work with a sensor that sits just under the skin and measures a person's glucose levels every few minutes in order to provide them with a bigger picture of where their glucose levels are and where they're heading. As of now, a transmitter attached to that sensor lets you see readouts of those levels on a smartphone or even an Apple Watch, but soon you'll also be able to see them on Ionic's screen. Dexcom and Fitbit say they're hoping to get this feature available to Ionic users in 2018 and are working to develop other diabetes management tools in the future. "We believe that providing Dexcom CGM data on Fitbit Ionic, and making that experience available to users of both Android and iOS devices, will have a positive impact on the way people manage their diabetes," said Dexcom's CEO, Kevin Sayer, in a statement. Continue reading >>

Does Fitbit Have Time To Pull Off Its Digital Healthcare Transformation?

Does Fitbit Have Time To Pull Off Its Digital Healthcare Transformation?

Does Fitbit have time to pull off its digital healthcare transformation? Fitbit's grand plan to pivot to software, data and services in the healthcare industry makes total sense. The big question is whether it'll have the time to pull it off use its device business to fund a business model pivot. Fitbit is embarking on a multi-year business transformation to pivot to software, healthcare services and data and analysts, but has to keep its wearable and smartwatch business humming long enough to fund it. The ongoing debate around Fitbit will revolve around whether the company has the time to execute its business model shift. Fitbit had a rough fourth quarter and its first quarter outlook was even worse. Fitbit reported a fourth quarter net loss of $46 million, or 19 cents a share, on revenue of $571 million. Non-GAAP loss per share in the fourth quarter was 2 cents a share. Previously: Fitbit buys startup Twine Health to grow health services, revenue | Fitbit Q1 outlook stumbles amid business model pivot | Fitbit aims for device to data pivot: Can you monetize 90 billion hours of heart rate data, 85 trillion steps? | Fitbit teams with Dexcom for glucose monitoring on Ionic watch | UnitedHealthcare, Qualcomm Life, Fitbit aim to expand corporate wellness As for the first quarter, Fitbit said it would see limited revenue from new products and a sales decline of 15 percent to 20 percent to $240 million to $255 million and a non-GAAP loss of 18 cents a share to 21 cents a share. Fitbit sees 2018 revenue of about $1.5 billion and plans to cut expenses another 7 percent. Anyone watching Fitbit for a while knows the challenges and opportunities. The breakdown goes like this: Wearable trackers are losing favor to smartwatches. Fitbit has to compete with much larger rivals in smar Continue reading >>

More in blood sugar